1Al'Abadie MS, Kent GC, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and othe skin conditions. Br J Dermatol, 1994,130(2):199-203.
2Rajychaudhuri SP, Rein G, Farber EM. Neuropathogenesis and neuropharmacology of psoriasis. Int J Dermatol, 1995,34(10):685-693.
3Farber EM, Rein G, Lanigan SW. Sress and psoriasis, psychoneuro-immunologic mecharnisms. Int J Dermatol, 1991,30(1):8-12.
4Jiang WY, Raychaudhuri SP, Farber EM. Double-labeled immunofluorescence study of cotaneous nerves in psoriasis. Int J Dermatol, 1998,37(8):572-574.
5Park YM, Kim CW. The effects of substance P and vasoactive intestinal poptide on interleukin-6 synthesis in cultured human keratinocytes. J Dermatol Sci, 1999,22(1):17-23.
6Raychaudhuri SK, Raychaudhuri SP, Weltan H, et al. Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res, 2001,293(6):291-295.
7Staniek V, Doutremepuich J, Schmitt D, et al. Expession of substance P receptors in normal and psoriatic skin. Pathobiology, 1999,67(1):51-54.
8Kakurai M, Fujita N, Murata S, et al. Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type 1 vasoactive intestinal peptide receptors. J Invest Dermatol, 2001,116(5):743-749.
9Bull HA, Leslie TA, Chopra S, et al. Expression of nerve growth factor receptors in cutaneous inflammation. Br J Dermatol, 1998,139(5):776-783.
10giasuddin AS, El-Sherif AI, El-Ojali SI. Prolactin: dose it have a role in the pathogenesis of psoriasis? dermatology, 1998,197(2):119-122.
